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Abstract: Background: Acacia farnesiana (AF) pods have been traditionally used to treat dyspepsia,
diarrhea and topically for dermal inflammation. Main objectives: (1) investigate the antioxidant
activity and protection against oxidative-induced damage of six extracts from AF pods and (2) their
capacity to curb the inflammation process as well as to down-regulate the pro-inflammatory mediators.
Methods: Five organic extracts (chloroformic, hexanic, ketonic, methanolic, methanolic:aqueous
and one aqueous extract) were obtained and analyzed by UPLC-ESI-Q-oa/TOF-MS. Antioxidant
activity (DPPH•, ORAC and FRAP assays) and lipid peroxidation (TBARS assay) were performed.
Assessment of anti-inflammatory properties was made by the ear edema induced model in CD-1 mice
and MPO activity assay. Likewise, histological analysis, IL-1β, IL-6, IL-10, TNF-α, COX measurements
plus nitrite and immunohistochemistry analysis were carried out. Results: Methyl gallate, gallic acid,
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galloyl glucose isomer 1, galloyl glucose isomer 2, galloyl glucose isomer 3, digalloyl glucose isomer
1, digalloyl glucose isomer 2, digalloyl glucose isomer 3, digalloyl glucose isomer 4, hydroxytyrosol
acetate, quinic acid, and caffeoylmalic acid were identified. Both organic and aqueous extracts
displayed antioxidant activity. All extracts exhibited a positive effect on the interleukins, COX and
immunohistochemistry assays. Conclusion: All AF pod extracts can be effective as antioxidant and
topical anti-inflammatory agents.
Keywords: Acacia farnesiana pods; antioxidant and anti-inflammatory activities; bioactive
compounds; polyphenols
1. Introduction
The loss of the prooxidant-antioxidant balance in biological systems is responsible of many
disorders resulting in oxidative damage [1]. Phytochemicals from plants help to maintain this
equilibrium by enhancing the scavenging properties against reactive oxygen species (ROS) [2].
Also, inflammation is a biological process that responds to several internal and external agents
and aggressors as infection or injuries which can turn into pathological and chronic stages affecting
to the host [3]. Plant bioactive compounds are capable of down-regulating the activation of the
mediators involved in the inflammatory cascade [4–6]. Bioactivity of phytochemicals to counteract
inflammation is enhanced if plant bioactive compounds are tested as extracts [7–9]. Phenols are the
frequent chemical group closely related to these effects [10,11]. Acacia genus contains phenols and
some other phytochemicals like amines, alcaloids, essential oils, non-protein aminoacids, cumarines,
diterpenes, fatty acids, triterpenes, phytosterols, saponines, flavonoids, gums and tannins. Bioactivity
and health promoting properties of these phytochemicals include the abatement of some chronical
disorders e.g., cancer, obesity, aging and diabetes [12]. In pods, leaves, stems, barks, flowers, and roots
of Acacia farnesiana (L.) Willd (family: Fabeceae), commonly named as sweet acacia or Huizache,
it has been described the occurrence of phytochemicals like albumin, gallic acid, glutelins, kaempferol,
quercetin, methyl gallate, myricetin, naringenin, diosmetin, apigenin, catechin, ellagic acid, lupeol,
α-amyrin, β-amyrin, β-sitosterol, ferulic and caffeic acids, among others. In this way, recently
Hernández [13], isolated and described the structural characteristic of three new compounds in
hexanic-cloroformic extract from AF pods: (3β,22E)-stigmasta-5,22-dien-3-ol, β-D-glucopyranoside,
(3β,22E)-stigmasta-5,22-dien-3-yl and (2S)-2,3-dihydroxypropyl tetracosanoate. Some of which have
been pointed out as protectors against ROS-induced damage [14]. Particularly, A. farnesiana (AF) pods
have been previously recognized as resource of phytochemicals with effective protective properties
against oxidative stress and antibacterial activity [13,15,16]. The consumption of AF as infusions
and/or decoctions includes antidiarrheal, antispasmodic and anti-hyperglycemic uses and alleviation
of dyspepsia [17,18].
The use of edible plants and their recommendations to alleviate health disorders, require
exhaustive investigation to support the benefits or limitations. The aims of this study were: (1) to
investigate the antioxidant activity and protection against oxidative induced damage of six extracts
[chloroformic (CE), hexanic (HE), ketonic (KE), methanolic (ME), methanolic:aqueous (80:20 v/v);
(MEAE) and one aqueous (AE)] from AF pod and (2) to test the same six extracts for their capacity to
curb the inflammation process as well as to down-regulate the pro-inflammatory mediators.
2. Results
2.1. Total Polyphenols Content
Total polyphenols content from CE, HE, KE, ME, MAE and AE from AF pods were 506, 620, 594,
378, 399 and 565 mg of equivalents of gallic acid/100 g of dry matter, respectively. These results keep
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up a correspondence with non-polar and polar properties of solvents as well as their ability to extract
phenolic units from AF pods.
2.2. AF Pod Extracts Analyzed by UPLC-ESI-Q-oa-/TOF-MS
In the six extracts, 12 phenolic compounds were identified by UPLC-ESI-Q-oa-/TOF-MS analysis
which include: methyl gallate, gallic acid, galloyl glucose isomer 1, galloyl glucose isomer 2, galloyl
glucose isomer 3, digalloyl glucose isomer 1, digalloyl glucose isomer 2, digalloyl glucose isomer 3,
digalloyl glucose isomer 4, hydroxytyrosol acetate, quinic acid, and caffeoylmalic acid (Table 1). It is
worth mentioning that the methyl gallate was identified in the six extracts and the gallic acid was
found in the chloroformic, methanolic:aqueous and aqueous extracts (see all chromatographic spectra
extracts in Figure S1).
Table 1. Compounds identified in six extracts from Acacia farnesiana (AF) pods.
Peak Rt (min) [M− H]− (m/z) MolecularFormula Dominant Ion Fragment Assignment Reference
Chloroformic
1 0.866 387.0918 - 341.1011 (100) Unknow -
2 0.935 331.0602 C13H16O10 271.0561 (100) Galloyl glucose isomer 1 [19]
3 1.826 169.0484 C7H6O5 125.0678 (100) Gallic acid [20]
4 1.912 331.0612 C13H16O10 271.0566 (100) Galloyl glucose isomer 2 [19]
5 2.169 331.0610 C13H16O10 271.0572 (100) Galloyl glucose isomer 3 [19]
6 2.512 493.0616 - 271.0562 (100) Unknow -
7 4.673 183.0608 C8H8O 168.9363 (100) Methyl gallate [21]
8 4.776 483.0230 C20H20O14 - Digalloyl glucose isomer 1 [22]
9 4.982 483.0224 C20H20O14 - Digalloyl glucose isomer 2 [22]
Hexanic
1 0.866 387.0918 - 341.1011 (100) Unknow -
2 0.935 331.0602 C13H16O10 271.0561 (100) Galloyl glucose isomer 1 [19]
3 1.826 169.0484 C7H6O5 125.0678 (100) Gallic acid [20]
4 1.912 331.0612 C13H16O10 271.0566 (100) Galloyl glucose isomer 2 [19]
5 2.169 331.0610 C13H16O10 271.0572 (100) Galloyl glucose isomer 3 [19]
6 2.512 493.0616 - 271.0562 (100) Unknow -
7 4.673 183.0608 C8H8O 168.9363 (100) Methyl gallate [21]
8 4.776 483.0230 C20H20O14 - Digalloyl glucose isomer 1 [22]
9 4.982 483.0224 C20H20O14 - Digalloyl glucose isomer 2 [22]
Ketonic
1 0.917 331.0600 C13H16O10 271.0560 (45) 211.0483 (1) Galloyl glucose isomer 1 [19]
2 1.826 331.0605 C13H16O10 271.0565 (100) Galloyl glucose isomer 2 [19]
3 2.084 331.0597 C13H16O10 271.0559 (100) Galloyl glucose isomer 3 [19]
4 2.392 493.0606 - 271.0557 (17) 313.0538 (1)169.0465 (1) Unknow -
5 4.279 483.0223 C20H20O14 183.0624 (100) Digalloyl glucose isomer 1 [23]
6 4.588 183.0610 C8H8O 168.9363 (100) Methyl gallate [21]
7 4.691 483.0228 C20H20O14
271.0562 (15) 211.0498 (8)
169.0481 (49) 125.0660 (1) Digalloyl glucose isomer 2 [22]
8 4.914 483.0219 C20H20O14
271.0562 (36) 211.0494 (3)
169.0481 (28) 125.0646 (1) Digalloyl glucose isomer 3 [22]
9 5.051 483.0226 C20H20O14 - Digalloyl glucose isomer 4 [22]
10 5.651 401.0812 - - Unknow -
Methanolic
1 0.832 331.0601 C13H16O10
271.0561 (40) 169.0482 (1)
133.0557 (1) Galloyl glucose isomer 1 [19]
2 1.072 331.0606 C13H16O10 271.0565 (100) Galloyl glucose isomer 2 [19]
3 1.603 483.0223 C20H20O14 271.0487 (100) Digalloyl glucose isomer 1 [19]
4 1.912 483.0223 C20H20O14 271.0566 (100) Digalloyl glucose isomer 2 [19]
5 2.581 183.0606 C8H8O 168.9363 (100) Methyl gallate [21]
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Table 1. Cont.
Peak Rt (min) [M− H]− (m/z) MolecularFormula Dominant Ion Fragment Assignment Reference
Methanolic:
Aqueous
1 0.9 387.0913 - 377.0659 (40) 341.1000 (18) Unknow -
2 1.02 331.0603 C13H16O10 271.0562 (100) Galloyl glucose isomer 1 [19]
3 1.946 169.0483 C7H6O5 125.0661 (100) Gallic acid [19]
4 2.118 331.0606 C13H16O10 271.0565 (100) Galloyl glucose isomer 2 [19]
5 2.41 331.0611 C13H16O10 271.0569 (100) Galloyl glucose isomer 3 [19]
6 2.821 493.0619 - 271.0559 (100) Unknow -
7 4.965 183.0604 C8H8O 168.9363 (100) Methyl gallate [21]
8 5.171 483.0225 C20H20O14 271.0564 (100) Digalloyl glucose isomer 1 [22]
Aqueous
1 0.8666 195.0799 - 165.0759 (100) Hydroxytyrosol acetate [24]
2 1.02 133.0546 - 115.0463 (100) unknow -
3 1.26 191.0494 C7H12O6 111.0524 (100) Quinic acid [25]
4 1.398 295.0470 C13H12O8 - Caffeoylmalic acid [26]
5 1.929 169.0478 C7H6O5 125.0657 (100) Gallic acid [23]
6 4.879 183.0609 C8H8O 168.9363 (100) Methyl gallate [21]
2.3. The Effect of the Extracts on the Elimination of Radicals Is Concentration-Dependent
As the concentration of the extracts increased, the radical scavenging capacity tended to increase
as well (Figure 1A–G). No differences (p > 0.05) were observed among the six extracts when we
compared the same concentrations (1.2–300 µg/mL) against quercetin. However, quercetin increased
the scavenging capacity of DPPH• radical in the first five concentrations (from 1 to 30 µg/mL) and
towards the end of the assay (Figure 1A). In contrast, HE, KE, ME and MEAE showed a much lower
response to DPPH• discoloration at initial concentration and equated the other extracts at 300 µg/mL.
In the same line, CE and AE responded to 120 and 300 µg/mL. However, below 60 µg/mL no favorable
response was observed for the latest two extracts. In relation to IC50 value, quercetin showed the
best result (22 µg/mL), while with KE, AE, CE and HE it was necessary to increase the concentration
around to one, two, three and seven-fold more (respectively) than quercetin to scavenge 50 percent of
DPPH• radical (Figure 1H).
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statistically significant. In marked contrast to ORAC, the extracts were more active than quercetin in 
the FRAP assay. In the FRAP assay, the first five tested concentrations (from 0.6 to 12 mmoles of 
Trolox equivalents/g of extract) were not different among all the extracts (data not showed). The 
depicted concentration is 30 mmoles of Trolox equivalents/g of extract; where, ME was the most 
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of extract), no differences were observed. When we evaluated a particular extract at different 
concentration, we observed significant differences (p < 0.05). However, the highest concentration 
(300 mmoles of Trolox equivalents/g of extract) resulted in the best ferric-reducing antioxidant 
power. The values for this activity were: ME, 8.4; MEAE, 6.6; KE, 6.1; AE, 5.4; CE, 4.9 and HE, 3.4 μg 
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Figure 1. Scavenging capacity of the DPPH• radical (A–G) and inhibitory concentration 50%
(IC50) values (H) of different extracts from Acacia farnesiana pods. The data are the mean with the
standard deviation of three independent repetitions. CE = chloroformic extract; HE = hexanic extract;
KE = ketonic extract; E = ethanolic extract; EAE = methanolic:aqueous extract and AE = aqueous
extract; Q = quercetin. a,b,c,d,e Differ nt letters showed si fi t di ference (p < .05) in the same
extract at different concentrations (Kruskal–Wallis test).
2.4. Quantitative Antioxidant Activity
ORAC values of the different extracts evalu are show in Figure 2. All the extracts were
less active than quercetin. ong all the extracts, MEAE showed the best performance (516 µmoles
of Trolox equivalents/g of extract) followed by KE, ME, CE, HE and AE with 396, 388, 226, 136,
and 89 µmoles of Trolox equivalents/g of extract, respectively. Differences in showed values were
statistically significant. In marked contrast to ORAC, the extracts were more active than quercetin in
the FRAP assay. In the FRAP assay, the first five tested concentrations (from 0.6 to 12 mmoles of Trolox
equivalents/g of extract) were not different among all the extracts (data not showed). The depicted
concentratio is 30 mmoles of Trolox equivalents/g of extract; where, ME was the most efficient extract
to reduce Fe+3 to Fe+2 with 2.0 mmoles of Trolox equivalents/g of extract, follow d by MEAE, KE,
CE, AE and HE, wh ch needed 1.7, 1.6, 1.5, 1.5 and 1.4 mmoles of Trolox equivalents/g of extract,
respectively. However, this is not statistically different (p > 0.05). Si ilarly, when we evaluated the
six extracts at higher concentrations (60, 120 and 300 mmoles of Trolox equivalents/g of extract),
no differences were observed. When we evaluated a particular extract at different concentration,
we observed significant differences (p < 0.05). However, the highest concentration (300 mmoles of
Trolox equivalents/g of extract) resulted in the best ferric-reducing antioxidant power. The values for
this activity were: ME, 8.4; MEAE, 6.6; KE, 6.1; AE, 5.4; CE, 4.9 and HE, 3.4 µg Trolox equivalents/g,
respectively. Regarding to FRAP, we observed IC50 values of 1.8, 1.5, 2.0, 2.6, 2.0 and 1.9 for CE, HE,
KE, ME, MEAE and AE compared to 1.4 of quercetin.
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observed in the cellular lysis detected as brilliant green fluorescent spots. Quercetin showed the best 
protective capacity than extracts to inhibit the production of ROS (Figure 3B). In contrast, CE and KE 
demonstrated the poorest inhibition of ROS production. 
 
Figure 2. Total antioxidant activity of the extracts from Acacia farnesiana pods by oxygen radical
absorbance capacity (ORAC) and ferric-reducing antioxidant power (FRAP) assays. Q = quercetin;
CE = chloroformic extract; HE = hexanic extract; KE = ketonic extract; ME = methanolic extract;
MEAE = methanolic:aqueous extract and AE = aqueous extract. a,b,c,d,e,f Different letters showed
significant difference (p < 0.05) in the same extract at different concentrations (Kruskal–Wallis test).
Figure 3 compares the quantitative and qualitative basis the protective effect of extracts. We made
sure that extracts did not cause any pro-oxidative effect on cells at any of the tested concentrations.
Figure 3A shows a picture selection of cell cultures treated with extracts at 200 ppm since they were
the most representative to observe the contrasting effects of extracts over ROS production. An evident
difference between cells treated with DMEM alone or with H2O2 was observed in the cellular lysis
detected as brilliant green fluorescent spots. Quercetin showed the best protective capacity than
extracts to inhibit the production of ROS (Figure 3B). In contrast, CE and KE demonstrated the poorest
inhibition of ROS production.
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Figure 3. Representative images of reactive oxygen species (ROS) produced on porcine kidney
cells exposed to H2O2 and to 200 ppm of extracts of Acacia farnesiana pods (A) and ROS
quantification using 50, 100 and 200 ppm of extracts (B). H2O2 = hydrogen peroxide; Q = quercetin;
CE = chloroformic extract; HE = hexanic extract; KE = ketonic extract; ME = methanolic extract;
MEAE = methanolic:aqueous extract; AE = aqueous extract. a,b,c,d Different letters showed significant
difference (p < 0.05) among extracts and queretin at the same co centration (Kruskal–Wallis test).
2.5. Lipid Peroxidation Is Inhibited by All Extracts in a Dose-Dependent anner
Results of TBARS inhibition are shown in Figure 4. Inhibition of lipid peroxidati n was observed
in a dose-dependent mann r i all extracts. Methanoli extract decreased TBARS production in
93% with the smallest concentration (10 µg/mL; equivalent to 1.0 nmol of TBARS/mg of protein).
Moreover, 31.6 µg/mL equivalent to 0.5 nmol of TBARS/mg of protein of CE, KE and MEAE were
needed to reach over 90% of TBARS inhibition, while AE and HE resulted in the same inhibition
percentage with 56.2 µg/mL equivalent to 0.7 nmol of TBARS/mg of protein. In relation to quercetin,
it is noteworthy that with only 5.6 µg/mL equivalent to 3.5 nmol of TBARS/mg of protein resulted in
a TBARS inhibition over 60%. The 50% inhibitory concentration (IC50) values of the extracts on TBARS
production are showed in Figure 4H. The IC50 value of KE, ME and MEAE not showed a statistical
variation (p > 0.05) in espect to th standard quercetin. MEAE registered 3.4 nmol/mg, similar to ME;
while CE, HE and AE IC50 were around to two, th ee and five-folds of that conc ntration and were less
active than standard quercetin. Finally, KE and quercetin standard have similar values of IC50.
2.6. Acacia farnesiana Extracts Down Regulate Inflammation
In the ear edema model, all extracts diminished the ear tissue weight after TPA
(12-O-tetradecanoylphorbol-13-acetate) application. However, the extracts were less effective than
indomethacin to prevent edema (Figure 5A). Likewise, all extracts showed an inhibition on MPO
and IL-1β production (Figure 5B,C). Similar results were observed by IL-6 (Figure 5D), where the
production of this interleukin was inhibited by all the extracts (except by HE). For IL-10, TPA group
showed comparable values with respect to indomethacin, CE, HE and KE treatments. In contrast, ME,
MEAE and AE reduced the value of this anti-inflammatory cytokine (Figure 5E). TNF-α production
were inhibited by all groups treated with AF extracts, except in the groups treated with ME and MEAE
(Figure 5F).
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Figure 4. Inhibition of lipid peroxidation (A–G) and inhibitory concentration 50% (IC50) values
(H) of the extracts from AF pods and standard quercetin, quantified by lipid peroxidation (TBARS)
production. CE = chloroformic extract; HE = hexanic extract; KE = ketonic extract; ME = methanolic
extract; MEAE = methanolic:aqueous extract and AE = aqueous extract. Q = quercetin. The data are
the mean with the standard error of three independent repetitions. * p < 0.05 and ** p < 0.01 vs.
control group.
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2.7. Effect of Acacia farnesiana Extracts on Mice Ear Swelling 
Figure 6 shows the mice ear tissue swelling as well as the ear thickness due to the effect of 
extracts on the TPA-induced ear edema model. All the evaluated extracts were different from control 
(p < 0.001). A morphological change due to the aggressive agent (TPA) resulted in a marked swelling 
process, sub-epidermal layer and spongiosis (Figure 6A). After TPA application, MEAE decrease the 
thickness of the mice ears almost at the same extent than indomethacin (323 and 356 μm; MEAE and 
indomethacin, respectively). In contrast KE and ME did not show a satisfactory reduction of the 
mice ears thickness in relation to control (Figure 6B). 
Figure 5. Effect of different extracts from Acacia farnesiana pods and the anti-inflammatory indomethacin
(1 mg) on TPA-induced ear edema model. (A) ear edema measured at 4 h after TPA treatment
and (B) oxidative enzyme myeloperoxidase (MPO) activity in supernatants of homogenates from
TPA-treated ears. Levels of (C) interleukin-1β (D), interleukin-6 (E), interleukin-10 and (F) TNF-α
in supernatants of homogenates from ears after treatment with different extracts from AF pods.
TPA = 12-O-tetradecanoylphorbol acetate; In = indomethacin; CE = chloroformic extract; HE = hexanic
extract; KE = ketonic extract; ME = methanolic extract; MEAE = methanolic:aqueous extract and
AE = aqueous extract. Each bar represents the mean ± standard deviation (n = 6). * p < 0.05 and
** p < 0.001 with respect to TPA group.
2.7. Effect of Acacia farnesiana Extracts on Mice Ear Swelling
Figure 6 shows the mice ear tissue swelling as well as the ear thickness due to the effect of
extracts on the TPA-induced ear dema model. All the evaluated extr cts were different from control
(p < 0.001). A morphological change due to the aggressive gent (TPA) result d in a marked swelling
process, sub-epidermal layer and spongiosis (Figure 6A). After TPA application, MEAE decrease the
thickn of th mice ears lmost at the same extent than indomethacin (323 nd 356 µm; MEAE and
indomethacin, r spe tively). In contrast KE and ME did not sh w a s tisfactory reduction of the mice
ears thickness in lation to control (Figure 6B).
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2.8. Effect of Acacia farnesiana Extracts on TNF-α-Expressing Cells 
Figure 7 shows the inflammation post treatment with different extracts of Acacia farnesiana (AF) 
pods on the TPA-induced ear edema model, by the expression of TNF-α by immunohistochemistry. 
While TPA induced conspicuous release of the pro-inflammatory mediator in the ears, treatment 
with CE, HE, KE, ME and AE resulted in an evident reduction in TNF-α production similar to 
indomethacin, while MEAE was the only that did not reduce of the TNF-α expression. 
Figure 6. Histological features of mice ear tissue (A) stained with hematoxylin-eosin (200×
magnification) on mice ear tissue thickness by the effect of different extracts of Acacia farnesiana pods on
the TPA-induced ear edema model (B). TPA = 12-O-tetradecanoylphorbol acetate; In = indomethacin;
CE = chloroformic extract; HE = hexanic extract; KE = ketonic extract; ME = methanolic extract;
MEAE = methanolic:aqueous extract and AE = aqueous extract. Each bar represents the mean ±
standard deviation (n = 6). ** p < 0.001 with respect to TPA group.
2.8. Effect of Acacia farnesiana Extracts on TNF-α-Expressing Cells
Figure 7 shows the inflammation post treatment with different extracts of Acacia farnesiana (AF)
pods on the TPA-induced ear edema mod l, by the expression of TNF-α by immunohistochemistry.
While TPA induced onspicuous release of the pro-inflammat ry mediator in the ears, treat en with
CE, HE, KE, ME and AE resulted in an vident reduction in TNF-α pro uction similar to indomethacin,
while MEAE was the o ly that did not reduce of the TNF-α expression.
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2.9. Effect of Acacia farnesiana Extracts on COX Activity, Cell Viability and Nitrite Production
The inhibitory activity of cyclooxygenase (COX) is shown in Figure 8. CE, HE and KE evaluated
at 10 and 30 µg/mL were found to have inhibitory activity similar to control group (Celecoxib).
In contrast ME, MEAE and AE demonstrated lower ability to inhibit the prostaglandin synthesis.
The viability of RAW 264.7 cells treated with of lipopolysaccharides (LPS) of E. coli is shown in
Figure 9A. The percentage of viability was over 70% in all groups evaluated and was similar to
the control group (treated with oleanolic acid). Numerically, HE reported the highest value (96.9%)
while AE the lowest percentage of viability (71.3%), however, no significant difference was found.
With respect to the nitrite production (Figure 9B), HE showed the best inhibitory potential (7.4 µM).
Moreover, nitrite production of cells treated with any of the left extracts (any but HE), were between
oleic acid group (9.5 µM) and lipopolysaccharides group (13.5 µM) values.
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3. Discussion 
Salem et al. [27] analyzed Acacia nilotica pods extracts and isolated eight bioactive compounds, 
e.g., methyl gallate, gallic acid and 3 galloyl and digalloyl glucose isomers among others. In 
addition, with their results that confirmed anti-tumoral activity from pods extracts from this species, 
we have a coincidence of four of these compounds and confirmed its antioxidant and 
anti-inflammatory activity in the different extracts evaluated. 
Total polyphenols content from CE, HE, KE, ME, MEAE and AE from AF pods were 506, 620, 
594, 378, 399 and 565 equivalents of gallic acid, mg/100 g dry matter, respectively. Both results (yield 
Figure 8. Effect of different Acacia farnesiana extracts on prostaglandin pro ction. Cx = Celecoxib;
CE = chloroformic extract; HE = hexanic extr KE = ketonic extract; ME = methanolic extract;
MEAE ethanolic:aqueous extract and AE = aqu ous extract. The data are the mean with the
standar deviati n of three independent repetitions. Statistical difference was calculated in relation to
COX at 30 and 100 ppm. * p < 0.05. ** p < 0.001.
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Figure 9. (A) Viability of RAW 264.7 cells treated with of lipopolysaccharides (LPS) of E. coli (1 µg/mL),
oleanolic acid or different extracts (25 µg/mL) from Acacia farnesiana pods. (B) Nitrite concentration in
supernatants of RAW 264.7 cells treated with LPS of E. coli (1 µg/mL), oleanolic acid (Ole) different
extracts (25 µg/mL) from Acacia farnesiana (AF) pods. CE = chloroformic extract; HE = h xanic extract;
KE = ketonic extract; ME = me hanolic extract; MEAE = me hanolic:aqueous extract and AE = aqueous
extract. Each bar r presents mean ± standard deviation (n = 6). * p < 0.05 between extracts respect
to LPS.
3. Discussion
Salem et al. [27] analyzed Acacia nilotica pods extracts and isolated eight bioactive compou ds,
e.g., methyl gallate, gallic acid and 3 galloyl and digalloyl glucose isomers among others. In addition,
with their results that confirmed anti-tumoral activity from pods extracts from this species, we have a
coincidence of four of these compounds and confirmed its antioxidant and anti-inflammatory activity
in the different extracts evaluated.
Total polyphenols content from CE, HE, KE, ME, MEAE and AE from AF pods were 506, 620, 594,
378, 399 and 565 equivalents of gallic acid, mg/100 g dry matter, respectively. Both results (yield and
total polyphenols content) keep up a correspondence with non-polar and polar properties of solvents
as well as their ability to extract phenolic units from AF pods.
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The anti-inflammatory activity of these extracts against induced edema was confirmed when
the ME was employed in rodent models (rat and mice). According to these results our findings
with TLC and HPLC of HE and CE demonstrated the presence of both metabolites. Lin et al. [28]
indicated that betulinic acid is another compound with potent anti-inflammatory and cytotoxic activity
found in AF roots that might contribute to the beneficial properties of Acacia genus. Therefore, it is
highly desirable to further investigate the identification and isolation of bioactive compounds in
this species to characterize the phytochemicals responsible of the antioxidant and anti-inflammatory
activities here described. Other authors indicated that betulinic acid also could have antioxidant
activity [29], therefore it might contribute to the radical scavenging capacity of the chloroformic
extract, where this metabolite was found. All extracts evaluated revealed antioxidant activity but with
dissimilar responses among them. This observation is in line with the study of Delgadillo et al. [16]
who evaluated Acacia pods and found an antioxidant activity of 95% with 200 µg/mL. In the present
study, we observed a response near to 80% of antioxidant activity at 120 µg/mL. HE is the less polar
extract and resulted as the less active on DPPH• extract evaluation. Though, ME and HE were able to
remove lipidic compounds as triterpenoids with important scavenging capacity, HE was not capable
to intensify the antioxidant activity until it was tested at a higher concentration. Karoune et al. [30]
analyzed leaves and bark from A. albida. In that study, the IC50 results in DPPH• assay was similar
between the two extracts obtained with ethanol (27 and 29 µg/mL). The IC50 in our study by DPPH•
test resembled the ME with a value of 34 µg/mL. KE and MEAE were also similar to ME which were
less effective than quercetin. Moreover, the use of other extractants was not as effective as ethanol
employed in A. albida. Some other sources of variation among the results, apart from the polarity
nature of solvents and the different vegetal parts in both studies, are possibly related to the different
season of recollection, climate changes, distinct maturity stage and the different geographical sites of
sampling. However, the results of DPPH• assay are similar to ORAC assay outcomes. The MEAE
showed the best antioxidant activity among all extracts evaluated. It was 2.5 times less active than
quercetin, while aqueous extract was close to 15 times less active than the standard, resulting in the
least effective one. In marked contrast to ORAC test, the ME and MEAE were more active than the
standard to reduced Fe+3 to Fe+2 in the FRAP assay. Likely, hydroxycinnamic acids and flavonoids
are in large part responsible of the radical scavenging activity, since caffeic, cinnamic, chlorogenic,
and gallic acids as well as catechin and epicatechin are recognized as potent radical stabilizers [1,14,15].
Regarding to the protective activity of the extracts against harmful effects of H2O2 to cells,
at 200 ppm AF extract inhibited the production of reactive oxygen species better than 100 and 50 ppm.
MEAE was the most active extract to protect kidney cells while hexanic extract showed the lowest
activity. When we compared the protective effect of different extracts, MEAE resulted as the best
extract among all the others. However, this extract was less effective (2.4 fold) than quercetin at
200 ppm. AE and MEAE were the most effective in the three evaluated concentrations.
Acute inflammation is characterized by vasodilatation, leukocyte infiltration, inflammation
mediators release and edema. With respect to edema (weight) all extracts were different from TPA.
However, indomethacin was more effective to reduce edema weight with respect to AF extracts.
These results are in accordance to IL-6 and MPO; i.e., all extracts were different from TPA but were
less effective than indomethacin to reduce edema. Moreover, CE, HE, MEAE and AE were efficient
to reduce ear thickness as indomethacin did. It is important to point out that the topical application
of TPA alone elevated edema (thickness and weight) at larger extent than the rest of the extracts.
The presence of certain bioactive compounds with recognized potent antioxidant activity as gallic
acid, catechin, epicatechin found in KE, ME and MEAE measured by TBARS and DPPH• are close
related to the anti-inflammatory activity response. It is known that these antioxidants inhibit the
reactive oxygen species generation (e.g., H2O2) while increasing the scavenging activity [7]. Moreover,
the ORAC test and the prostaglandin production (COX) indicated that CE and HE are more successful
to scavenge the ROS than the rest of the extracts and to decrease the production of inflammatory
cytokines. Likewise, HE reduced the nitrite production from macrophages induced by LPS of E. coli.
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Because cytokines and prostaglandins are part of the mediators responsible of the inflammatory
pathways, the damage caused in the cell membranes was inhibited by the presence of lupeol,
α-amyrin and β-amyrin, which are compounds that increased the anti-inflammatory response by
decreasing the nitrite and the PGE2 levels by inhibition of the iNOS and COX expression, respectively,
according to Fernández et al. [31] and Adkins and Kelley [32]. Thus, triterpenes found in CE and HE
contributed to exert their anti-inflammatory activity by reducing cytokines such as TNF-α and IL-1β.
The mechanism of action of these bioactive compounds is through the modulation of the transcription
factor NF-κB [33,34]. The TNF-α expression is consistent with the findings of the protective effect
on porcine kidney cells and the immunohistochemistry of TNF-α antibody, since HE was the extract
with the lowest production of this pro-inflammatory cytokine. Our results agreed to those reported
by Horinouchi et al. [35] who evaluated the ethanolic extracts of flowers from Combretum leprosum.
In our study MPO activity, IL-6 levels and ear thickness diminished with the topical administration
of the extract and no pro-inflammatory activity was observed after the topical application of AF
extracts. However, indomethacin decreased ear edema, MPO activity and IL-6 at greater extent than
AF extracts. In the same line, Oliveira et al. [8] evaluated the ethanolic extract of aerial parts of
Leonurus sibiricus found similar results; i.e., reduction in the ear thickness, MPO activity; as well as the
concentration of TNF-α and IL-1β. Sánchez et al. [36] and Crispo et al. [37] indicated that functional
compounds as flavonoids are responsible of such anti-inflammatory and antioxidant protective actions.
Besides the important antioxidant activity, flavonoids interfered with the inflammation process [29].
The inhibition of arachidonic acid (C20:4 n-6) and prostaglandins biosynthesis (i.e., lipoxygenase,
phospholipase and cyclooxygenase activities) are included in the processes described for this desirable
effect. The metabolic pathway is supported by the investigation of Lin et al. [28] who demonstrated
that flavonoids constrain the expression and activation of the pro-inflammatory cytokines, TNF-α
and COX.
The results from TBARS assay are in accordance to the previous antioxidant assays. Lipid peroxidation
inhibition was dose-dependent and ME succeed among the other extracts using the smallest amount
to produce that effect, while AE and HE showed poor inhibition on TBARS production. These results
are in line with the information reported by Delgadillo et al. [16] who evaluated AF pods. The different
antioxidant activity measured by ORAC and FRAP, as well as the protection against H2O2-induced damage
and lipid peroxidation inhibition, may be the consequence of distinct phytochemicals found on each extract.
This might have different and enormous implications on biological responses involved, not only for cellular
functioning but also for potential therapeutic applications.
The contrasting activity, measured by ORAC and FRAP assays, also was observed by Ou et al. [38]
in the antioxidant characterization of 927 vegetables using these same assays and they concluded
that these differences are associated to specific chemical reactions involved in these antioxidant tests.
This disparity may be explained by the fact that both assays are based on different reaction mechanisms:
ORAC determination is based on hydrogen atom transference (HAT) and FRAP test on single electron
transfer (SET) reaction. The HAT mechanism occurs when the oxygen radical abstracts a hydrogen
atom from antioxidant while in SET reaction the antioxidant provides an electron to the free radical [39].
FRAP assay measures the ferric reducing ability of a sample, there are no presence of free radicals or
oxidants such as occurs in the ORAC assay. So, the antioxidant capacity of an antioxidant against a
free radical does not necessarily match its ability to reduce Fe3+ to Fe2+.
In addition to the antioxidant capacity, the differences in the protection against H2O2-induced damage
and lipid peroxidation inhibition, may be the consequence of distinct phytochemicals found on each extract.
4. Materials and Methods
4.1. Vegetal Collection and Plant Extracts
AF pods of the present study were collected in Acatlán de Osorio in the state of Puebla in México;
located between 18◦04′24′′ and 18◦21′30′′, north latitude and 97◦55′18′′ and 98◦11′24′′ west longitude.
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Acacia farnesiana–AF (name listed in: http://www.theplantlist.org; accessed on 22 September 2017)
pods were registered with an internal identification number (8757) at the herbarium of the Facultad de
Estudios Superiores Cuautitlán at the Universidad Nacional Autónoma de México (UNAM). Sampling
was performed on aerial parts of AF trees to complete two batches of 20 kg each, which were assessed
separately in the subsequent chemical analysis. Pods were completely dried in a drying stove of
atmospheric flow at 40 ◦C for 48 h and grounded using a knife mill to obtain a particle size of
1 mm. The pods of AF were treated individually with different solvents (chloroform, hexane, acetone,
methanol, methanol:water (80:20 v/v) or distilled water) as follows: 200 g of sample were weighed
and 500 mL of each solvent were added individually into five Erlenmeyer flasks and then sonicated
for 30 min at room temperature. Samples were filtered and concentrated on a rotary evaporator; water
bath was set at 40 ◦C for organic solvents and 60 ◦C for the aqueous extract. Flasks were washed with
the corresponding extractant (10 mL max) and then, the extracts were placed in a vacuum desiccator
for a week and stored at 4 ◦C in amber vials until analyzed. The solvents/aqueous extractions were
performed twice.
4.2. Total Phenolic Content
Total phenolic content in CE, HE, KE, ME, MEAE and AE of AF pods was determined by the
Folin–Ciocalteu colorimetric method described by Singleton et al. [40]. Briefly, 3 mg of each extract
were diluted into 1 mL of solvent. Dimethyl sulfoxide (DMSO) was used for HE and CE and distilled
water for the rest of the extracts. A half mL of each stock solution was transferred into a volumetric
flask and 3% HCl was added to a final volume of 5 mL. From the resulting solution, an aliquot of
100 µL was mixed with a 2 mL of 2% NaCO3 solution, letting stand during two minutes. Then,
100 µL of Folin–Ciocalteu reagent (previously diluted 1:1 v/v with water) were added to the latest
solution and incubated at room temperature during 30 min in darkness. Absorbance was measured
at 765 nm in a 3.0 mL UV-Quartz cell (Hach Co. cat. 48228-00, Loveland, CO, USA) using a UV
spectrophotometric equipment (Beckman, DU-70, Brea, CA, USA). A calibration curve of gallic acid
was prepared to estimate the concentration of total polyphenols and results were expressed as mg of
gallic acid equivalents (GAE) per 100 g of extract.
4.3. UPLC-ESI-Q-oa/TOF-MS Analysis
AF pod extracts were analyzed by Ultra Performance Liquid Chromatography (UPLC) and the
chromatographic separations were carried using a Beh Phenyl (2.1 mm × 100 mm, 1.7 mm; Waters,
Elstree, UK) analytical column operated at 40 ◦C. The mobile phase consisted of two solvents: formic
acid (0.1%, v/v) in water (A) and acetonitrile (B). The gradient program was used as follows: 97% A for
1.10 min, followed by multiple gradients from 5% B to 15% B from 1.10 to 4.40 min, holding 15% B for
4.60 min, getting back to the initial conditions (3% B) in 1 min and re-equilibration of the column. Mass
spectrometric analyses were performed using a quadrupole time of flight orthogonal accelerated mass
spectrometer with electrospray ionization (ESI-Q-oa-TOF-MS, Waters, UK). The solvent flow rate was
0.3 mL min−1 with a dry gas temperature of 210 ◦C, and a dry gas flow of 8.0 L min−1. ESI ionization
conditions were a capillary voltage of −3.5 and +4.0 kV, and spectra rate of 1 Hz. While, spectra
detection was carried out in the negative ion mode and recorded using a scan range m/z 50–1200 Da
using a ramp collision energy of 15–35 V with argon as collision gas. Finally, the identification
of the present compounds was determined by using the full mass spectrum and its unique mass
fragmentation spectrum and comparing them with the literature, using the NIST, MassBank, Pubchem
and mzCloud [https://www.mzcloud.org/] data bases.
4.4. Antioxidant Activity
To evaluate the quantitative antioxidant activity, DPPH• (2,2-diphenyl-1-picrylhydrazyl) reagent
was employed according to Koren et al. [41]. The antioxidant values of samples were compared with
standards of quercetin. To evaluate the peroxyl scavenging capacity by oxygen radical absorbance
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capacity (ORAC), the methodology of Huang et al. [42] was used. The results are reported as
micromoles of Trolox equivalents per gram of extract. Ferric reducing antioxidant power (FRAP)
was performed as previously described by Benzie and Strain [43]. The methodology used to evaluate
the defense of extracts against oxidative-induced damage was according to Hernández et al. [44] with
some modifications. Briefly, culture cells were seeded at a density of 20,000 per well, incubated in
48 well plates for 24 h. Three mg of each extract were diluted into one mL of solvent (3 mg/mL).
DMSO was employed for HE and CE and distilled water for the rest of the extracts. Three different
dilutions were prepared to obtain final concentrations of 50, 100 and 200 ppm in Dulbecco’s modified
eagle medium (DMEM), 300 µL from each solution were added to the plates. In the same well
plate, a hydrogen peroxide (H2O2) solution was added as external oxidant (47 µL, 1 mM) during 2 h.
All extracts were evaluated in triplicate.
Lipid peroxidation was evaluated by measuring the thiobarbituric acid reactive substances
(TBARS). Cerebral tissue (whole brain) of adult male Wistar rats (200–250 g body weight) was
homogenized using phosphate buffer saline (PBS) that was centrifuged (radius of 90 mm) for 10 min
at 3000 rpm to yield a pellet, which was discarded. The supernatant protein content was measured
using the Lowry et al. [45] methodology and adjusted at 2.666 mg of protein/mL with PBS.
The TBARS quantification was employed according to the method described by Ohkawa et
al. [46] with some modifications. Using a bath ice and 1.5 mL micro centrifuge tubes, 375 µL of the
supernatant (equivalent to 1 mg of protein) were mixed with 50 µL of EDTA (20 µM in saline). Stock
solutions were previously prepared (3 mg/mL) as follows: HE and CE were dissolved in DMSO,
and the rest of the extracts in distilled water to get the corresponding dilutions. Then, 25 µL of each
extract solution were added to the reaction tube, followed by an incubation for 30 min at 37 ◦C and
shaking. Lipid peroxidation was triggered by adding 50 µL of 100 µM Fe2SO4 solution and incubated
at 37 ◦C for 1 h under the same conditions described above. TBARS content was determined as
follows: 0.5 mL of TBA reagent (0.5% TBA in 0.05 N NaOH and 30% TCA, 1:1 v/v) was added at
each tube and the final suspension was cooled on ice for 10 min, centrifuged (5 min at 12,000 rpm;
radius of 90 mm) and heated at 75 ◦C in a water bath for 30 min. After cooling at room temperature,
the absorbance (200 µL) was measured at λ = 540 nm in a microplate reader (Bio-Tek Instruments,
Winooski, VT, USA). Concentration of TBARS was calculated by interpolation in a standard curve of
tetramthoxypropane [47]. Results were expressed as nmol of TBARS per mg of protein. Quercetin was
used as a positive standard. The inhibition ratio (IR [%]) was calculated using the following formula
IR = (C − E/C) × 100, where C is the absorbance of control and E is the absorbance of the sample.
These values were plotted against the log of the concentrations of individual extracts, and a decrease
of 50% in peroxidation was defined as the EC50.
4.5. Anti-Inflammatory Activity
4.5.1. Animal Experimental Set Up
The experimental animals (male CD-1 mice; average live weight 25–30 g) were obtained from
the Universidad Autónoma Metropolitana-Xochimilco (UPEAL-Bioterio, DCBS.BIOT.390.16), Mexico
City. Animals (eight groups with six animals each one), were housed at 22 ± 4 ◦C with 12/12 h
light-darkness cycles and relative humidity of 40–70% at the Instituto de Química UNAM. Food and
plain water were provided ad libitum. All experimental procedures followed the recommendations of
the Mexican Federal Regulation (NOM-062-ZOO-1999). Protocols for maintenance, sample collection
and euthanasia were reviewed and approved by the internal committee for the care and the use of lab
animals of the Instituto de Química at UNAM (CICUAL-IQ-004-17).
4.5.2. Ear Edema Essay in CD-1 Mice Induced with 12-O-tetradecanoylphorbol Acetate (TPA)
This essay was performed according to Del-Ángel et al. [48] with some modifications. 20 µL of
solutions of the six extracts at a concentration of 3 mg/ear and indomethacin as standard (1 mg/ear)
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were used. To facilitate the miscibility of the samples, for CE and HE extracts, chloroform was
used as vehicle while methanol was used for KE, ME, MEAE and AE extracts. For the standard
(indomethacin), the vehicle solution used was a mixture of acetone and methanol (1:1). Solutions were
homogenized with a vortex during 30 s. On other hand, the rodents were previously anesthetized
with an intraperitoneal injection of sodium pentobarbital (63 mg/kg) to produce general anesthesia
during 20 to 50 min. Palpebral, patellar and ocular reflexes were monitored to confirm adequate
anesthesia of mice. Subsequently 10 µL of ethanolic solution of TPA (250 µg/mL) were applied on top
of the right ear of the mice. Ten minutes later, on top of the same ear (right ear) either 20 µL of the
extracts or indomethacin were applied. On top of the left ear (control ear) of mice, 10 µL of ethanol
plus 20 µL of the corresponding vehicle solution were applied. After these procedures, mice were
located into a sand-dust bedded plastic box over a heater (26–28 ◦C) to avoid thermic stress during
the recovery period from anesthesia. Once mice were fully recovered, they were transferred to a new
plastic box and were monitored during four hours. After this period, the euthanasia was performed
in a CO2 chamber. Round biopsies of 7 mm of diameter in both ears from each mouse were taken
using a straight punch tool (ACE surgical supply CO., Inc.). Biopsies were weighed and the edema
inhibition (%) was obtained using the following formula: percentage of inhibition = (C−E/C) × 100;
where C = was the edema in the positive control group (TPA application alone); E = edema in the
experimental groups treated with either AF extracts or indomethacin [48].
4.5.3. Oxidative Enzyme Myeloperoxidase Assay (MPO)
Ears biopsies (preserved at −80 ◦C) coming from the TPA-induced edema test were used for this
assessment. The methodology used for this essay was carried out in agreement with the reports of
Suzuki et al. [49] and Bradley et al. [50]. The inhibition of the MPO activity was calculated using the
formula: Percentage of MPO inhibition = ODC−ODE/ODC × 100; where ODC = optical density at
450 nm of control group (ethanol plus extracts or standard) and ODE = optical density at 450 nm of
experimental groups (TPA plus extracts or standard).
4.5.4. Histological Analysis of Ear
The employed methodology for this essay was carried out according to previous reports [49,50].
For this analysis, we used complete ears of CD-1 mouse from the TPA-induced edema test. The ears
were immediately fixed in 10% formaldehyde. A train of dehydration was used; i.e., ear samples were
sinked successively during 30 min into each of the following solvents: ethanol (50%), ethanol (60%),
ethanol (70%), ethanol (80%), ethanol (96%), ethanol (100%) and xylol (100%). Once the biological
sample was dry, were embedded in paraffin (60 ◦C) and cut into sections (4 µm slices) and stained with
hematoxylin and eosin. The tissues were observed under a microscope (Leica DM750 Wetzlar, Hesse,
Germany), photographed using a digital camera (Leica DMC2900) and processed with the imaging
software Leica LAS Core V4.5 (Bufallo Grove, IL, USA).
4.5.5. Immunohistochemistry
The assay was performed according to Leal-Díaz et al. [51] and Méndez-Flores et al. [52] with
some modifications. Tumor necrosis factor (TNF)-α expressing cells were determined in 4 µm
thick sections of available formalin-fixed paraffin embedded tissue. Endogenous peroxidase and
binding of nonspecific proteins were blocked with 3% H2O2 and 10% of normal donkey serum (ABC
Staining System; Santa Cruz Biotechnology, Dallas, TX, USA), respectively. Tissues were incubated
with rabbit monoclonal anti-rat TNF-α antibody (Merck Millipore, Billerica, MA, USA) diluted to
10 µg/mL and let stand for 18 h at 4 ◦C. Binding was identified with biotinylated secondary antibody
and horseradish peroxidase-(HRP)-streptavidin (ABC Staining System; Santa Cruz Biotechnology).
Slides were incubated with substrate 3,3′-diaminobenzidine (DAB) (Sigma-Aldrich, St. Louis. MO,
USA) for 10 min. The sections were counterstained with hematoxylin, dehydrated and mounted in
resin. Negative control staining was performed with normal donkey serum diluted 1:100, instead of
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primary antibody, and the immunohistochemistry (IHC) universal negative control reagent specifically
designed to work with rabbit, mouse, and goat antibodies (IHC universal negative control reagent,
Enzo Life Sciences, Inc., Farmingdale, NY, USA, ADI-950-231). The reactive blank was incubated
with phosphate buffer saline-egg albumin (Sigma-Aldrich) instead of the primary antibody. Both
controls excluded nonspecific staining or endogenous enzymatic activities. The tissues were observed,
photographed and processed as above described.
4.5.6. Quantitation of IL-1β, IL-6, IL-10 and Tumor Necrosis Factor α (TNF-α) from Ear Extracts
Ear punches were homogenized with 500 mL of cold lysis buffer (Merck), centrifuged and stored
at −80 ◦C until analyzed. Interleukin (IL) IL-1β, IL-6, IL-10 and the TNF-α from ears biopsies coming
from the TPA-induced edema test were analyzed using a 96-well plate of Milliplex MAP kit, with a
mouse cytokine/chemokine multiplex magnetic bead panel (Cat. MCYTOMAG-70K, Merck). Samples
were analyzed in a MAGPIX luminometer and the concentration of each metabolite calculated with a
5-parameter polynomial standard curves ranging from 0.65 to 10,000 pg/mL using the xPonent 4.2
software (Luminex Corporation, Austin, TX, USA). All samples from each treatment were analyzed
simultaneously to minimize error.
4.6. In Vitro COX Inhibition and Nitrite Assay
The first in vitro assay was performed in a COX inhibitor screening kit (Cayman Chemical
Company, Ann Arbor, MI, USA) according to Del-Ángel et al. [48] as well as the in vitro nitrite assay,
which include: (1) the culture of RAW 264.7 cells; (2) the nitrite assay where cells were treated with
lipopolysaccharides (E. coli, serotype 055 B5) to observe production of nitric oxide (NO); and (3) the cell
viability assay by the incorporation of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) by RAW 264.7 cells.
4.7. Statistical Analysis
Non-parametric Kruskal–Wallis test was used to compare groups while U de Mann-Whitney test
was employed to observe differences among peers (α = 0.05). SPSS statistic software was used (18th V.
IBM Corp, Armonk, NY, USA).
5. Conclusions
Acacia farnesiana pod extracts can be effective as antioxidant and as topical anti-inflammatory
agents. This investigation helps to support the traditional use of this vegetal resource as alternative
medicine. No clear evidence was observed among the six extracts to identify the best extractant to
endorse both antioxidant and anti-inflammatory properties. Therefore, it is necessary to continue the
research in this vegetal resource to elucidate the molecular mechanism of these activities which make
this plant a real opportunity to consider as an alternative source of such compounds. Additionally,
the same pod extracts are under evaluation to elucidate their capacity to act as antitubercular and
antidysenteric agent. The inclusion of AF pods in ruminant diets will be conducted to observe the
modification of milk in terms of bioactive constituents present for human consumption.
Supplementary Materials: Supplementary Materials are available online. Figure S1: Chromatographic spectra of
AF extracts.
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